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Objectives
Acute coronary syndrome (ACS) is the most 
important clinical consequence of coronary artery 
disease and a leading cause of death worldwide. 
This study aims to assess the costs of ACS from a 
social and health insurance perspective evaluating 
direct costs, production losses and intangible costs 
in terms of quality adjusted life years (QALYs) lost.
Conclusions 
ACS causes considerable costs in terms of direct 
medical expenditures, lost production and premature 
death, even without taking into account costs for its 
chronic consequences such as congestive heart failure. 
Distinction between cost per patient and cost per 
hospital stay is crucial for cost-effectiveness analysis.
Results
14’955 patients experienced an ACS event in 2008; 
2’752 died as a consequence (table 1). ACS lead to 
19’064 hospital stays with an average length of stay in 
acute care of 8.9 days per patient. Total direct costs 
amounted to 690 Mio Swiss Francs (CHF) for the 
society (table 2) and 523 Mio CHF for health insurers. 
44% belong to inpatient and 56% to outpatient services. 
Production losses were 519 Mio. CHF and intangible 
costs resulted in 37'457 QALYs lost. Results appear 
robust in sensitivity analysis.
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All inpatient treatments in 2008 are considered as well as 
outpatient treatments from ACS in 2008 until death. Note that 
the study does not consider inpatient treatments provided in 
2009 and following years (example 3) nor possible ambulatory 
treatment before a 1st ACS event in 2008 (example 5).
Methods
A bottom-up incidence approach was used. ACS-
patients with one or more ACS events were extracted 
from a national hospital database [1] and from 
mortality statistics [2] (figure 1). Remaining life years 
of surviving patients were modelled on age, gender 
and life expectancy statistics. 
Inpatient costs include acute care and rehabilitation in 
2008. Outpatient costs include costs for ambulance, 
visits to GP and cardiologist, outpatient diagnostics, 
medication and rehabilitation. Production losses 
calculated according to human capital approach, 
include absenteeism, permanent disability and 
premature death. Intangible costs were calculated 
based on literature data [3]. Cost data are derived 
from official price lists, literature and experts. 
Validation of clinical data was conducted using the 
AMIS-PLUS registry.
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sequence 
of stay UAP NSTEMI STEMI rehab total
1 2'884 4'818 5'529 0 13'231
2 341 1'067 1'427 1'459 4'294
3 60 213 330 605 1'208
4-9 28 59 59 185 331
total 3'313 6'157 7'345 2'249 19'064
Many patients experience multiple inpatient stays in course of ACS 
treatment (e.g. transfer to other hospital or rehabilitation clinic).
Figure 1: ACS events and consequent treatments 
considered our study
Table 1: Number of patients with ACS in 2008
direct medical costs (Mio. CHF)
9.34 1.4 before hospitalisation
270.34 39.2 acute care hospital
30.29 4.4 inpatient rehabilitation
41.48 6.0 outpatient 1st year
26.11 3.8 outpatient 2nd year
312.92 45.3 outpatient from 3d year on
690.48 100.0 total direct costs
production losses  (Mio. CHF)
518.98 100.0 total production losses
intangible costs  (QALYs)
37'457 100.0 total QALY loss
Table 2: Total costs of ACS in 2008
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13'231 patients in hospital with at least one ACS [1]
-1'028 of which died in hospital [1]
2'752 fatalities due to ACS [2]
14'955 patients with at least one ACS event in 2008
